Company intelligence / Profile preview

BankInvest

Ownership: Private
Development stage: Other

Overview

BankInvest Biomedical Venture is a Danish-based venture capital fund established in 1998 that invests primarily in biotech drug development companies across Europe and the US. It has supported more than 30 portfolio companies through seven different funds. The fund typically participates in investment rounds alongside other major VCs and has a track record of exits above industry average. Its investments focus on medical and healthcare startups aged 4–5 years at time of investment, including notable names like Genmab, F2G, and Nereus Pharmaceuticals.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Investors

Partnerships

Novartis Venture FundPacific Venture GroupGimvRoche Venture Fund

Beyond the preview

Go deeper on BankInvest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BankInvest.

Explore the full profile